Jones Hill Capital »

Insmed shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $13M 122k 106.62

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Gilead Sciences (GILD)
Arcutis Biotherapeutics (ARQT)
Madrigal Pharmaceuticals (MDGL)
Bicara Therapeutics (BCAX)
Relmada Therapeutics (RLMD)
Trevi Therapeutics (TRVI)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Biosante Pharmaceuticals (ANIP)
Immunocore Hldgs Ads (IMCR)
Amylyx Pharmaceuticals (AMLX)
Insmed Com Par $.01 (INSM)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)

View all positions for Jones Hill Capital

Top funds holding Insmed

FMR
BlackRock
Jpmorgan Chase & Co
Vanguard Portfolio Management
Vanguard Capital Management
Baker Bros. Advisors
Capital Research and Management Company - Division 3
Darwin Global Management
Ameriprise Financial
Orbis Allan Gray
D. E. Shaw & Co
State Street Corporation
Artisan Partners Limited Partnership
Rtw Investments
Geode Capital Management

View all funds holding Insmed